pI: 11.0815 |
Length (AA): 203 |
MW (Da): 23581 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
10 | 94 | 1s3a (A) | 15 | 96 | 24.00 | 0 | 0.89 | 0.8 | -0.98 |
11 | 98 | 1s3a (A) | 16 | 98 | 25.00 | 0 | 1 | 0.863298 | -1.47 |
19 | 113 | 4jxt (A) | 14 | 114 | 34.00 | 0.4 | 0.18 | 0.81598 | -0.96 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 merozoite, ME49 Bradyzoite. | Hehl AB Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Oocyst. | Fritz HM |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_128975)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G59650 | mitochondrial ribosomal protein L51/S25/CI-B8 family protein |
Babesia bovis | BBOV_II004580 | conserved hypothetical protein |
Brugia malayi | Bm1_49770 | Mitochondrial ribosomal protein L51 / S25 / CI-B8 domain containing protein |
Candida albicans | CaO19.5279 | likely mitochondrial ribosomal protein similar to S. cerevisiae MRPL51 (YPR100W) large subunit protein (human MRP-L43) |
Candida albicans | CaO19.12744 | likely mitochondrial ribosomal protein similar to S. cerevisiae MRPL51 (YPR100W) large subunit protein (human MRP-L43) |
Caenorhabditis elegans | CELE_C25A1.13 | Protein MRPL-34 |
Dictyostelium discoideum | DDB_G0283273 | hypothetical protein |
Drosophila melanogaster | Dmel_CG5479 | mitochondrial ribosomal protein L43 |
Echinococcus granulosus | EgrG_000204900 | mitochondrial ribosomal protein l43 |
Echinococcus multilocularis | EmuJ_000204900 | mitochondrial ribosomal protein l43 |
Homo sapiens | ENSG00000055950 | mitochondrial ribosomal protein L43 |
Loa Loa (eye worm) | LOAG_08660 | hypothetical protein |
Mus musculus | ENSMUSG00000025208 | mitochondrial ribosomal protein L43 |
Neospora caninum | NCLIV_041520 | hypothetical protein, conserved |
Oryza sativa | 9266128 | Os03g0207250 |
Plasmodium berghei | PBANKA_1208400 | ribosomal protein L43, mitochondrial, putative |
Plasmodium falciparum | PF3D7_1010000 | ribosomal protein L43, mitochondrial, putative |
Plasmodium knowlesi | PKNH_0809800 | ribosomal protein L43, mitochondrial, putative |
Plasmodium vivax | PVX_094720 | ribosomal protein L43, mitochondrial, putative |
Plasmodium yoelii | PY04009 | hypothetical protein |
Saccharomyces cerevisiae | YPR100W | mitochondrial 54S ribosomal protein MRPL51 |
Schistosoma japonicum | Sjp_0214730 | ko:K03946 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 2, putative |
Schistosoma mansoni | Smp_034430.2 | 39S ribosomal protein L43 |
Toxoplasma gondii | TGME49_289140 | ribosomal protein l22/l43, putative |
Theileria parva | TP02_0297 | hypothetical protein, conserved |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C25A1.13 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_1208400 | Plasmodium berghei | Essential | plasmo |
TGME49_289140 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.